Cleveland Clinic Health System Obligated Group - FMSbonds.com

Cleveland Clinic Health System Obligated Group - FMSbonds.com Cleveland Clinic Health System Obligated Group - FMSbonds.com

09.07.2015 Views

Cleveland Clinic Health SystemNotes to Consolidated Financial Statements (continued)3. Accounting Policies (continued)Impairment of Long-Lived AssetsThe System evaluates the recoverability of long-lived assets and the related estimated remaininglives at each balance sheet date. The System records an impairment charge or changes the usefullife if events or changes in circumstances indicate that the carrying amount may not berecoverable or the useful life has changed.Investments and Investment IncomeInvestments in equity securities with readily determinable market values and all investments indebt securities are measured at fair value, based on quoted market prices, in the consolidatedbalance sheets and are classified as trading, excluding one investment with a value of $8.3million at December 31, 2007, which is classified as nontrading. Realized gains and losses aredetermined using the average cost method.Investments in alternative investments are primarily limited partnerships that invest inmarketable securities, privately held securities, real estate, and derivative products and arereported using the equity method of accounting based on information provided by the respectivepartnership. The values provided by the respective partnerships are based on historical cost,appraisals, or other estimates that require varying degrees of judgment. If no public market existsfor the alternative investment, the fair value is determined by the general partner taking intoconsideration, among other things, the cost of the securities, prices of recent significantplacements of securities of the same issuer, and subsequent developments concerning thecompanies to which the securities relate. There is inherent uncertainty in such valuations and theestimated fair values may differ from the values that would have been used had a ready marketfor the securities existed. Generally, the fair value of the System’s holdings in alternativeinvestments reflects net contributions to the partnership and an ownership share of realized andunrealized investment income and expenses. The investments may individually expose theSystem to securities lending, short sales, and trading in futures and forward contract options andother derivative products. The System’s risk is limited to its carrying value. Amounts can bedivested only at specified times in accordance with terms of the partnership agreement. Thefinancial statements of the limited partnerships are audited annually.12

Cleveland Clinic Health SystemNotes to Consolidated Financial Statements (continued)3. Accounting Policies (continued)Investment income on investments, including changes in equity values of alternativeinvestments, is reported as nonoperating gains and losses except for earnings on funds held bybond trustees and assets held for self-insurance, which are included in other unrestrictedrevenues ($6.6 million and $11.8 million in 2007 and 2006, respectively). Donor restrictedinvestment income on temporarily and permanently restricted investments, including realizedand unrealized gains and losses, is included in temporarily restricted net assets. An unrealizedgain of $8.3 million at December 31, 2007 associated with the investment classified asnontrading is included in unrestricted net assets.Alternative investments also includes investments related to venture fund investments directlyowned by the System aggregating $4.4 million and $5.0 million at December 31, 2007 and 2006,respectively, which are recorded on the cost method. In 2007 and 2006, the System recorded aprovision for the impairment of certain venture fund investments of $0.6 million and $0.3million, respectively, which is included in nonoperating gains and losses.Financial InstrumentsThe carrying values of cash and cash equivalents, accounts receivable and accounts payable arereasonable estimates of fair value due to the short-term nature of these financial instruments. AtDecember 31, 2007 and 2006, the fair value of the System’s long-term debt, as estimated bydiscounted cash flow analyses using current borrowing rates for similar types of borrowingarrangements, was $1,482 million and $1,509 million (Note 11), respectively. Other noncurrentassets and liabilities have carrying values that approximate fair value.In September 2006, the Financial Accounting Standards Board (FASB) issued FASB Statementof Financial Accounting Standard (SFAS) No. 157, Fair Value Measurements (SFAS No. 157),which establishes a framework for using fair value to measure assets and liabilities, and expandsdisclosures about fair value measurements. SFAS No. 157 applies to other accountingpronouncements that require or permit fair value measurements and, accordingly, SFAS No. 157does not require any new fair value measurements. SFAS No. 157 is effective for financialstatements issued for fiscal years beginning after November 15, 2007, and interim periods withinthose fiscal years. The System is currently evaluating the potential impact that the adoption ofthis statement will have on its financial position and results of operations.13

<strong>Cleveland</strong> <strong>Clinic</strong> <strong>Health</strong> <strong>System</strong>Notes to Consolidated Financial Statements (continued)3. Accounting Policies (continued)Investment in<strong>com</strong>e on investments, including changes in equity values of alternativeinvestments, is reported as nonoperating gains and losses except for earnings on funds held bybond trustees and assets held for self-insurance, which are included in other unrestrictedrevenues ($6.6 million and $11.8 million in 2007 and 2006, respectively). Donor restrictedinvestment in<strong>com</strong>e on temporarily and permanently restricted investments, including realizedand unrealized gains and losses, is included in temporarily restricted net assets. An unrealizedgain of $8.3 million at December 31, 2007 associated with the investment classified asnontrading is included in unrestricted net assets.Alternative investments also includes investments related to venture fund investments directlyowned by the <strong>System</strong> aggregating $4.4 million and $5.0 million at December 31, 2007 and 2006,respectively, which are recorded on the cost method. In 2007 and 2006, the <strong>System</strong> recorded aprovision for the impairment of certain venture fund investments of $0.6 million and $0.3million, respectively, which is included in nonoperating gains and losses.Financial InstrumentsThe carrying values of cash and cash equivalents, accounts receivable and accounts payable arereasonable estimates of fair value due to the short-term nature of these financial instruments. AtDecember 31, 2007 and 2006, the fair value of the <strong>System</strong>’s long-term debt, as estimated bydiscounted cash flow analyses using current borrowing rates for similar types of borrowingarrangements, was $1,482 million and $1,509 million (Note 11), respectively. Other noncurrentassets and liabilities have carrying values that approximate fair value.In September 2006, the Financial Accounting Standards Board (FASB) issued FASB Statementof Financial Accounting Standard (SFAS) No. 157, Fair Value Measurements (SFAS No. 157),which establishes a framework for using fair value to measure assets and liabilities, and expandsdisclosures about fair value measurements. SFAS No. 157 applies to other accountingpronouncements that require or permit fair value measurements and, accordingly, SFAS No. 157does not require any new fair value measurements. SFAS No. 157 is effective for financialstatements issued for fiscal years beginning after November 15, 2007, and interim periods withinthose fiscal years. The <strong>System</strong> is currently evaluating the potential impact that the adoption ofthis statement will have on its financial position and results of operations.13

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!